Literature DB >> 23056775

Placental chorioangioma as the cause of non-immunologic hydrops fetalis; a case report.

Eduardo Alfredo Duro1, Ines Moussou.   

Abstract

BACKGROUND: Chorioangiomas are the most common benign tumors of the placenta originating from primitive angioblastic tissues. It comprises near 1 percent of placental tumors. Clinical manifestations in the newborn are rare and usually associated with tumors greater than 5 cm in diameter and consist of polyhydramnios, fetal anemia, massive edema with pleural effusion, ascites and intrauterine growth retardation. We present a case with large chorioangioma as the cause of non-immunologic hydrops fetalis with a successful outcome. CASE
PRESENTATION: The patient was a female newborn with history of polyhydramnios, symptoms of congestive heart failure and associated anemia, thrombocytopenia and coagulopathy. The pathophysiology and management of the complications of hydrops fetalis with chorioangioma are discussed
CONCLUSION: Chorioangioma of the placenta has potentially serious perinatal risks and so the pregnancy needs to have regular surveillance. The chance of developing complications is directly related with the tumor size.

Entities:  

Keywords:  Chorioangioma; Fetal Anemia; Fetal Cardiac Failure; Hydrops Fetalis; Placental Tumors

Year:  2011        PMID: 23056775      PMCID: PMC3446109     

Source DB:  PubMed          Journal:  Iran J Pediatr        ISSN: 2008-2142            Impact factor:   0.364


Introduction

The term non-immunologic hydrops fetalis (NIHF) defins an edematous fetus with fluid collections in some or all serous cavities that does not have erythroblastosis fetalis from isoimmunization. In 1943 Dr Edith Potter published the first description of NIHF[1]; now over 80 conditions are known to be associated with hydrops with very high perinatal mortality ranging from structural heart disease, fetal arrhythmias, chromosomal anomalies, intrauterine infections and larger chorioangiomas of the placenta[2-5]. In most countries with low rhesus-negative rates in the population, nonimmune causes are more prevalent; the incidence depends on the region and also varies seasonally in relation to parvovirus B19 epidemics. We describe a newborn in whom cardiac enlargement and congestive heart failure were caused by a vascular shunt through a large placental chorioangioma, emphasizing the importance of the anatomical study of the placenta for the correct diagnosis, managing the neonatal care and evolution of the newborn.

Case Presentation

A 2.120g preterm female newborn, product of a non consanguineous marriage was born from a primigravida by emergency cesarean section at 32 weeks of gestation because ultrasound examination revealed cardiomegaly with abnormal umbilical flow and signs of vascular fetal insufficiency. Physical examination at birth revealed 1 minute Apgar score 8, anasarca, poor respiratory effort with bilateral wet rales, hepatosplenomegaly with ascites and no reflexes. Coombs test in cord blood and the infant's blood was negative. The initial chest radiograph obtained 2 hours after birth showed soft tissue edema, cardiomegaly and pleural effusion compatible with congestive heart failure. Abdominal radiography showed ascites with soft tissue edema, and hepatosplenomegaly. The newborn was put on mechanical ventilation for the first few days of life. Serial electrocardiograms showed low voltage complexes with right ventricular hypertrophy. Echocardiogram showed a dilated right ventricle with pericardial effusion. Laboratory data included hypoproteinemia and hypoalbuminemia, anemia (hematocrit 31%; hemoglobin 10.3mg/dl) and hyponatremia (Na 125 mEq/l), thrombocytopenia (platelets 41×109/l) and deranged coagulation profile (prothrombin time 19 seconds, activated partial thromboplastin time 120 seconds). Cultures of blood, urine, and ascitic fluid were negative. Serologic studies for infectious diseases related to NIHF were also negative. The infant's cardiorespiratory status gradually improved with water restriction, conventional respiratory assistance and inotropic drugs which resulted in 29 percent decrease in weight compared to her birth weight. Pathology of the placenta showed edema without signs of placental infarction and a big tumoral mass measuring 10×4×3cm (Fig. 1). Microscopic examination revealed large fusiform vessels in a fibrotic stroma with focal edema and clusters of myxoid cells (Fig. 2 and 3).
Fig. 1

Placental chorioangioma: Tumoral mass measuring 10×4×3cm

Fig. 2

Placental chorioangioma: Large fusiform vessels in a fibrotic stroma with focal edema and clusters of myxoid cells

Placental chorioangioma: Tumoral mass measuring 10×4×3cm Placental chorioangioma: Large fusiform vessels in a fibrotic stroma with focal edema and clusters of myxoid cells

Discussion

Placental chorioangioma is a benign vascular tumor detected in 1 percent of placentas after systematic examination. Only 10% of these are macroscopically visible. Most of these tumors are small and discovered only by microscopic examination and have no adverse impact on the fetus. Larger tumors are rare and when above 5 cm in diameter, they are associated with serious complications. These tumors are found accidentally by ultrasound examination[6]. In our case, the placental tumor measured more than 10cm and led to cardiomegaly with abnormalities in the umbilical flow and signs of vascular fetal insufficiency. The vascularization of the tumor is a determinant factor of perinatal outcome. Where the tumor is avascular, no specific complications should be expected. When the tumor is vascularized, and in particular if it contains numerous large vessels, serial ultrasound and Doppler examinations are warranted to detect early features of fetal congestive heart failure[7]. Two hypotheses are proposed for formation of congestive heart failure in this condition: The left to right shunt as a result of intra tumoral arteriovenous shunting and chronic fetal hypoxia secondary to insufficient placental function or anemia and thrombocytopenia[8, 9]. Anemia is sometimes secondary to fetomaternal hemorrhage, or blood sequestration in the tumor. The detection of ultrasound findings of heart failure or suggestive signs of anemia as cardiomegaly, enlargement of the liver and abnormal umbilical vein. Doppler sonograhy may be useful for diagnostic purposes before NHF developed signs and symptoms. Large placental chorioangiomas are rare and the prognosis is bad when a big tumor causes fetal hemodynamic changes with NIHF, but treatment of heart failure may be promising in these newborns and complete recovery is achieved in some cases.

Conclusion

Chorioangioma of the placenta has potentially serious perinatal risks and so the pregnancy needs to have regular surveillance. The chance of developing complications is directly related with the tumor size.
  8 in total

1.  Large placental chorioangioma.

Authors:  A Mancuso; R D'Anna; F Corrado; M L Cannata
Journal:  Acta Obstet Gynecol Scand       Date:  2001-10       Impact factor: 3.636

2.  Cardiomegaly in a Newborn Due to Placental Chorioangioma.

Authors:  P F Benson; M C Joseph
Journal:  Br Med J       Date:  1961-01-14

3.  Antenatal classification of hydrops fetalis.

Authors:  J Santolaya; D Alley; R Jaffe; S L Warsof
Journal:  Obstet Gynecol       Date:  1992-02       Impact factor: 7.661

4.  Non-immunologic hydrops fetalis associated with a large hemangioendothelioma.

Authors:  S J Daniel; G Cassady
Journal:  Pediatrics       Date:  1968-11       Impact factor: 7.124

5.  Color flow mapping and Doppler velocimetry in the diagnosis and management of a placental chorioangioma associated with nonimmune fetal hydrops.

Authors:  G I Hirata; D I Masaki; M O'Toole; A L Medearis; L D Platt
Journal:  Obstet Gynecol       Date:  1993-05       Impact factor: 7.661

6.  Microangiopathic hemolytic anemia and thrombocytopenia in a neonate associated with a large placental chorioangioma.

Authors:  C R Bauer; R M Fojaco; E Bancalari; L Fernandez-Rocha
Journal:  Pediatrics       Date:  1978-10       Impact factor: 7.124

Review 7.  Placental chorioangioma: prenatal diagnosis and clinical significance.

Authors:  H A Hadi; J Finley; D Strickland
Journal:  Am J Perinatol       Date:  1993-03       Impact factor: 1.862

8.  Three-dimensional sonography of placental mesenchymal dysplasia and its differential diagnosis.

Authors:  Edi Vaisbuch; Roberto Romero; Juan Pedro Kusanovic; Offer Erez; Shali Mazaki-Tovi; Francesca Gotsch; Chong Jai Kim; Jung-Sun Kim; Lami Yeo; Sonia S Hassan
Journal:  J Ultrasound Med       Date:  2009-03       Impact factor: 2.153

  8 in total
  4 in total

1.  Unusual complications of placental chorioangioma: consumption coagulopathy and hypertension in a preterm newborn.

Authors:  Thangaraj Abiramalatha; Betsy Sherba; Reny Joseph; Niranjan Thomas
Journal:  BMJ Case Rep       Date:  2016-05-06

2.  Placental tumor (chorioangioma) as a cause of polyhydramnios: a case report.

Authors:  Nabil Abdalla; Michal Bachanek; Seweryn Trojanowski; Krzysztof Cendrowski; Wlodzimierz Sawicki
Journal:  Int J Womens Health       Date:  2014-11-20

3.  Safety of vaginal delivery in women with placental chorioangiomas diagnosed by prenatal ultrasound: A retrospective cohort study.

Authors:  Jiashan Zou; Weimin Ding; Qin Chen; Xiaoxia Bai; Baohua Li
Journal:  Medicine (Baltimore)       Date:  2022-07-22       Impact factor: 1.817

Review 4.  Can ultrasound be helpful in selecting optimal management methods for pregnancies complicated by placental non-trophpblastic tumors?

Authors:  Nabil Abdalla; Robert Piórkowski; Paweł Stanirowski; Monika Pazura; Krzysztof Cendrowski; Włodzimierz Sawicki
Journal:  J Ultrason       Date:  2017-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.